Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.65 USD | +0.35% | +17.21% | +48.37% |
Apr. 19 | TScan Therapeutics Closes $150.1 Million Securities Offering | MT |
Apr. 17 | TScan Therapeutics Prices $150.1 Million Public Offering of Shares, Warrants | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.37% | 493M | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- TCRX Stock
- News TScan Therapeutics, Inc.
- TScan Therapeutics Receives FDA Approval for TSC-203-A0201's Investigational New Drug Application